All Stories
Featured Stories
Evaluating Innovations in Middle Molecule Clearance
Heart, Kidney & Metabolic Care: A Strategic Imperative for Health Systems
SGLT2 Inhibitors Could Play Role in Slowing Kidney Disease Progression
This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
-
RPA Panel: DaVita Chief Transformation Officer Calls for Acceleration of Value-Based Models, Focus on Upstream Care
At the annual Renal Physicians Association (RPA) meeting in Dallas, Texas, March 24-27, DaVita chief transformation officer Misha Palecek spoke candidly about the nephrology community’s…
-
Social Workers as Educators: A Critical Role in the Kidney Transplant Journey
More than half of the people who receive dialysis start their treatment in an emergent, unplanned way often called “crashing.” The sudden discovery that a regular, life-sustaining treatment…
-
DaVita’s New Home CMO Considers How to Increase Access to Home Dialysis
For Dr. Mihran Naljayan, the two keys to increasing patient access to home dialysis are clear—health equity and education. Recently named DaVita’s new chief medical officer (CMO) of Home…
-
DaVita Celebrates Donors During National Donate Life Month
Nearly 100,000 people in the U.S. need a kidney transplant,[1] but limited availability of organs for people on the wait list can result in long wait times. For some transplant candidates, living…
-
DaVita Celebrates Its Teammates in 2022 Villagewide Conference
DaVita’s internal conference, Villagewide, returned March 29–30, 2022. This event highlights and celebrates teammates (employees) and provides updates and accomplishments around the…
